BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CgA AND Diagnosis
42 results:

  • 1. Diagnostic dilemma in a patient with history of medullary thyroid carcinoma and abnormal serum liver enzymes; a case report with six years follow up.
    Rahmani F; Tohidi M; Azmoudeh-Ardalan F; Sadeghi A; Hadaegh F
    BMC Endocr Disord; 2023 Aug; 23(1):186. PubMed ID: 37649029
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
    Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report.
    Nisman B; Oleinikov K; Nechushtan H; Maimon O; Atlan K; Peled N; Gross D; Peretz T; Meirovitz A; Grozinsky-Glasberg S
    J Thorac Oncol; 2023 Mar; 18(3):369-376. PubMed ID: 36503175
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung cancer.
    Xinli W; Lixiao W; Baoqi D; Hu H; Qiang Z
    Biomed Res Int; 2022; 2022():1707914. PubMed ID: 35402616
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Neuroendocrine tumors (NETs) - experience of a single Center.
    Şincu MC; Cocuz IG; Tinca AC; Niculescu R; Sabău AH; Chiorean DM; Morariu SH; Cotoi OS
    Rom J Morphol Embryol; 2021; 62(2):457-463. PubMed ID: 35024733
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]    [Full Text] [Related]  

  • 7. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
    Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
    Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
    Zheng ZG; Sun WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnostic Utility of INSM1 in Medullary thyroid Carcinoma.
    Seok JY; Kang M; De Peralta-Venturina M; Fan X
    Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.
    Hu L; Xie X
    Diagn Pathol; 2020 Dec; 15(1):142. PubMed ID: 33317559
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors.
    Whitt J; Hong WS; Telange RR; Lin CP; Bibb J; Beebe DJ; Chen H; Jaskula-Sztul R
    Cancer Gene Ther; 2020 Dec; 27(12):898-909. PubMed ID: 32029905
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interpretation of Unexpectedly High Levels of Endocrine Tumor Markers.
    Yu R
    Endocr Pract; 2018 Sep; 24(9):841-847. PubMed ID: 30106635
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Primary carcinoid of ovary: a clinicopathologic analysis of 17 cases].
    Zhu R; Xue XW; Luo YF; Wu HW; Huo Z
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):339-343. PubMed ID: 29783799
    [No Abstract]    [Full Text] [Related]  

  • 14. Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame.
    Marotta V; Zatelli MC; Sciammarella C; Ambrosio MR; Bondanelli M; Colao A; Faggiano A
    Endocr Relat Cancer; 2018 Jan; 25(1):R11-R29. PubMed ID: 29066503
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
    Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
    Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [One case of throat B-cell lymphoma with ipsilateral thyroid papillary carcinoma].
    Cui Z; Zhou B; Deng Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1220-1. PubMed ID: 24617009
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Diagnostic value of microtubule-associated protein-2 in small cell lung carcinoma: an analysis of 240 biopsy cases].
    Zhou DM; Sun Y; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):321-4. PubMed ID: 24004589
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Chromogranin A and neuroendocrine tumors].
    Díaz Pérez JÁ; Currás Freixes M
    Endocrinol Nutr; 2013; 60(7):386-95. PubMed ID: 23271036
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases.
    Li JD; Zhuang Y; Li YF; Feng YL; Hou JH; Chen L; Zhu AN; Wu QL; Yun JP
    J Clin Pathol; 2011 Dec; 64(12):1102-7. PubMed ID: 21965825
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.